Stem cells in alginate bioscaffolds

Therapeutic Delivery

Volumn 3, Issue 6, 2012, Pages 761-774

  Garate, Ane ^a,b   Murua, Ainhoa ^a,b   Orive, Gorka ^a,b   Hernández, Rosa M ^a,b   Pedraz, Jose Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; MOLECULAR SCAFFOLD;

BONE DISEASE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL FATE; CHONDROPATHY; DRUG DELIVERY SYSTEM; EMBRYONIC STEM CELL; GLIOBLASTOMA; HEART INFARCTION; HUMAN; IMMOBILIZED CELL; INSULIN DEPENDENT DIABETES MELLITUS; MESENCHYMAL STEM CELL; NERVE REGENERATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84861793138     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.53     Document Type: Review

References (148)

1. Borlongan CV, Skinner SJ, Geaney M, Vasconcellos AV, Elliott RB, Emerich DF. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease. Neuroreport 15, 2521-2525 (2004).
2. Calafiore R, Basta G, Luca G et al. Standard technical procedures for microencapsulation of human islets for graft into non-immunosuppressed patients with type 1 diabetes mellitus. Transplant. Proc. 38, 1156-1157 (2006).
3. Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 87, 5095-5103 (1996).
4. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 10, 682-692 (2009).
5. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910 (1980).
6. Tam SK, De Haan BJ, Faas MM, Halle JP, Yahia L, De Vos P. Adsorption of human immunoglobulin to implantable alginate-poly-l-lysine microcapsules: Effect of microcapsule composition. J. Biomed. Mater. Res. A. 89, 609-615 (2009).
7. Gugerli R, Cantana E, Heinzen C, von Stockar U, Marison IW. Quantitative study of the production and properties of alginate/ poly-l-lysine microcapsules. J. Microencapsul. 19, 571-590 (2002).
8. Orive G, Tam SK, Pedraz JL, Halle JP. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 27, 3691-3700 (2006).
9. Murua A, Herran E, Orive G et al. Design of a composite drug delivery system to prolong functionality of cell-based scaffolds. Int. J. Pharm. 407, 142-150 (2011).
10. De Haan BJ, Rossi A, Faas MM et al. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid. J. Biomed. Mater. Res. A 98, 394-403 (2011).
11. McQuilling JP, Arenas-Herrera J, Childers C et al. New alginate microcapsule system for angiogenic protein delivery and immunoisolation of islets for transplantation in the rat omentum pouch. Transplant. Proc. 43, 3262-3264 (2011).
12. Kolambkar YM, Dupont KM, Boerckel JD et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32, 65-74 (2011).
13. Popa EG, Gomes ME, Reis RL. Cell delivery systems using alginate-carrageenan hydrogel beads and fibers for regenerative medicine applications. Biomacromolecules 12, 3952-3961 (2011).
14. Remminghorst U, Rehm BH. Bacterial alginates: From biosynthesis to applications. Biotechnol. Lett. 28, 1701-1712 (2006).
15. Drury JL, Dennis RG, Mooney DJ. The tensile properties of alginate hydrogels. Biomaterials 25, 3187-3199 (2004).
16. Martinsen A, Skjak-Braek G, Smidsrod O. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol. Bioeng. 33, 79-89 (1989).
17. Lee KY, Mooney DJ. Alginate: Properties and biomedical applications. Prog. Polym. Sci. 37, 106-126 (2012).
18. Amsden B, Turner N. Diffusion characteristics of calcium alginate gels. Biotechnol. Bioeng. 65, 605-610 (1999).
19. King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mater. Res. 57, 374-383 (2001).
20. Pawar SN, Edgar KJ. Alginate derivatization: A review of chemistry, properties and applications. Biomaterials 33, 3279-3305 (2012).
21. Morch YA, Donati I, Strand BL, Skjak-Braek G. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules 7, 1471-1480 (2006).
22. Krishnamurthy NV, Gimi B. Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit. Rev. Biomed. Eng. 39, 473-491 (2011).
23. Zimmermann H, Hillgartner M, Manz B et al. Fabrication of homogeneously cross-linked, functional alginate microcapsules validated by NMR-, CLSM- and AFM-imaging. Biomaterials 24, 2083-2096 (2003).
24. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689 (2006).
25. Chiu RC. MSC immune tolerance in cellular cardiomyoplasty. Semin. Thorac. Cardiovasc. Surg. 20, 115-118 (2008).
26. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26, 7095-7103 (2005).
27. Augello A, Kurth TB, De Bari C. Mesenchymal stem cells: A perspective from in vitro cultures to in vivo migration and niches. Eur. Cell. Mater. 20, 121-133 (2010).
28. Paul A, Nayan M, Khan AA, Shum-Tim D, Prakash S. Angiopoietin-1- expressing adipose stem cells genetically modified with baculovirus nanocomplex: Investigation in rat heart with acute infarction. Int. J. Nanomed. 7, 663-682 (2012).
29. Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998-1000 (2000).
30. Nair A, Shen J, Lotfi P, Ko CY, Zhang CC, Tang L. Biomaterial implants mediate autologous stem cell recruitment in mice. Acta Biomater. 7, 3887-3895 (2011).
31. Salinas CN, Anseth KS. Mesenchymal stem cells for craniofacial tissue regeneration: Designing hydrogel delivery vehicles. J. Dent. Res. 88, 681-692 (2009).
32. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 414, 98-104 (2004).
33. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45-53 (1999).
34. Hui TY, Cheung KM, Cheung WL, Chan D, Chan BP. In vitro chondrogenic differentiation of human mesenchymal stem cells in collagen microspheres: Influence of cell seeding density and collagen concentration. Biomaterials 29, 3201-3212 (2008).
35. Moreau JL, Xu HH. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. Biomaterials 30, 2675-2682 (2009).
36. Salinas CN, Anseth KS. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J. Tissue Eng. Regen. Med. 2, 296-304 (2008).
37. Salinas CN, Anseth KS. Decorin moieties tethered into PEG networks induce chondrogenesis of human mesenchymal stem cells. J. Biomed. Mater. Res. A 90, 456-464 (2009).
38. Chayosumrit M, Tuch B, Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 31, 505-514 (2010).
39. Santos E, Zarate J, Orive G, Hernandez RM, Pedraz JL. Biomaterials in cell microencapsulation. Adv. Exp. Med. Biol. 670, 5-21 (2010).
40. Zimmermann H, Zimmermann D, Reuss R et al. Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J. Mater. Sci. Mater. Med. 16, 491-501 (2005).
41. De Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27, 5603-5617 (2006).
42. Ma HL, Hung SC, Lin SY, Chen YL, Lo WH. Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J. Biomed. Mater. Res. A 64, 273-281 (2003).
43. Tompkins RG, Carter EA, Carlson JD, Yarmush ML. Enzymatic function of alginate immobilized rat hepatocytes. Biotechnol. Bioeng. 31, 11-18 (1988).
44. Shakibaei M, De Souza P. Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads. Cell Biol. Int. 21, 75-86 (1997).
45. Caterson EJ, Li WJ, Nesti LJ, Albert T, Danielson K, Tuan RS. Polymer/alginate amalgam for cartilage-tissue engineering. Ann. NY Acad. Sci. 961, 134-138 (2002).
46. Kavalkovich KW, Boynton RE, Murphy JM, Barry F. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system. In Vitro Cell. Dev. Biol. Anim. 38, 457-466 (2002).
47. Buxboim A, Discher DE. Stem cells feel the difference. Nat. Methods 7, 695-697 (2010).
48. Boontheekul T, Kong HJ, Mooney DJ. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26, 2455-2465 (2005).
49. Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 60, 217-223 (2002).
50. Hsiong SX, Huebsch N, Fischbach C, Kong HJ, Mooney DJ. Integrin-Adhesion ligand bond formation of preosteoblasts and stem cells in three-dimensional RGD presenting matrices. Biomacromolecules 9, 1843-1851 (2008).
51. Grellier M, Granja PL, Fricain JC et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30, 3271-3278 (2009).
52. Evangelista MB, Hsiong SX, Fernandes R et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 28, 3644-3655 (2007).
53. Banerjee A, Arha M, Choudhary S et al. The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells. Biomaterials 30, 4695-4699 (2009).
54. Karsenty G. The complexities of skeletal biology. Nature 423, 316-318 (2003).
55. Kronenberg HM. Developmental regulation of the growth plate. Nature 423, 332-336 (2003).
56. Benoit DS, Schwartz MP, Durney AR, Anseth KS. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat. Mater. 7, 816-823 (2008).
57. Li L, Davidovich AE, Schloss JM et al. Neural lineage differentiation of embryonic stem cells within alginate microbeads. Biomaterials 32, 4489-4497 (2011).
58. Beltrami AP, Cesselli D, Beltrami CA. Stem cell senescence and regenerative paradigms. Clin. Pharmacol. Ther. 91, 21-29 (2012).
59. Hipp J, Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: New paradigms for therapy. J. Exp. Clin. Assist. Reprod. 1, 3 (2004).
60. Sumi S. Regenerative medicine for insulin deficiency: Creation of pancreatic islets and bioartificial pancreas. J. Hepato. Pancreat. Sci. 18, 6-12 (2011).
61. Facca S, Cortez C, Mendoza-Palomares C et al. Active multilayered capsules for in vivo bone formation. Proc. Natl Acad. Sci. USA 107, 3406-3411 (2010).
62. Bian L, Zhai DY, Tous E, Rai R, Mauck RL, Burdick JA. Enhanced MSC chondrogenesis following delivery of TGF-beta3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 32, 6425-6434 (2011).
63. Bai HY, Chen GA, Mao GH, Song TR, Wang YX. Three step derivation of cartilage like tissue from human embryonic stem cells by 2D-3D sequential culture in vitro and further implantation in vivo on alginate/PLGA scaffolds. J. Biomed. Mater. Res. A 94, 539-546 (2010).
64. Seidlits SK, Khaing ZZ, Petersen RR et al. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation. Biomaterials 31, 3930-3940 (2010).
65. Zhu Y, Liu T, Song K, Ning R, Ma X, Cui Z. ADSCs differentiated into cardiomyocytes in cardiac microenvironment. Mol. Cell. Biochem. 324, 117-129 (2009).
66. Mobasheri A, Csaki C, Clutterbuck AL, Rahmanzadeh M, Shakibaei M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: Applications in cartilage repair and osteoarthritis therapy. Histol. Histopathol. 24, 347-366 (2009).
67. Hwang YS, Cho J, Tay F et al. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 30, 499-507 (2009).
68. Kraehenbuehl TP, Ferreira LS, Hayward AM et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32, 1102-1109 (2011).
69. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 292, F1626-F1635 (2007).
70. Leipzig ND, Shoichet MS. The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials 30, 6867-6878 (2009).
71. Cai J, Huang Y, Chen X, Xie H, Huang Y, Deng L. Regulation of sonic hedgehog on vascular endothelial growth factor, basic fibroblast growth factor expression and secretion in bone marrow mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26, 112-116 (2012).
72. Zhou B, Tsaknakis G, Coldwell KE et al. A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. Br. J. Haematol. 157, 299-311 (2012).
73. Hsiao ST, Asgari A, Lokmic Z et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. (2012) (Epub ahead of print).
74. Huang YC, Liu TJ. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/ tripolyphosphate/fucoidan nanoparticles. Acta Biomater. 8, 1048-1056 (2012).
75. Tasso R, Gaetani M, Molino E et al. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 33, 2086-2096 (2012).
76. Kisseleva T, Brenner DA. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J. Hepatol. 56(4), 965-972 (2012).
77. Liu H, Lu K, Macary PA et al. Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells. J. Cell. Sci. 125, 200-208 (2012).
78. Gehmert S, Gehmert S, Hidayat M et al. Angiogenesis: The role of PDGF-BB on adiopse-tissue derived stem cells (ASCs). Clin. Hemorheol. Microcirc. 48, 5-13 (2011).
79. Amado LC, Saliaris AP, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl Acad. Sci. USA 102, 11474-11479 (2005).
80. Das H, George JC, Joseph M et al. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS ONE 4, e7325 (2009).
81. Yu J, Du KT, Fang Q et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 31, 7012-7020 (2010).
82. Park JS, Shim MS, Shim SH et al. Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-beta3. Biomaterials 32, 8139-8149 (2011).
83. Bae SE, Choi DH, Han DK, Park K. Effect of temporally controlled release of dexamethasone on in vivo chondrogenic differentiation of mesenchymal stromal cells. J. Control. Release 143, 23-30 (2010).
84. Choi DH, Park CH, Kim IH, Chun HJ, Park K, Han DK. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. J. Control. Release 147, 193-201 (2010).
85. Springer ML, Hortelano G, Bouley DM, Wong J, Kraft PE, Blau HM. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J. Gene Med. 2, 279-288 (2000).
86. Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768-15773 (2009).
87. Naftanel MA, Harlan DM. Pancreatic islet transplantation. PLoS Med. 1, e5875 (2004).
88. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet 373, 1808-1817 (2009).
89. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389-1394 (2001).
90. Godfrey KJ, Mathew B, Bulman JC, Shah O, Clement S, Gallicano GI. Stem cell-based treatments for Type 1 diabetes mellitus: Bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Diabet.Med. 29(1), 14-23 (2011).
91. Gabr MM, Sobh MM, Zakaria MM, Refaie AF, Ghoneim MA. Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats. Exp. Clin. Transplant. 6, 236-243 (2008).
92. Ngoc PK, Phuc PV, Nhung TH, Thuy DT, Nguyet NT. Improving the efficacy of Type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells. Hum. Cell 24, 86-95 (2011).
93. Wang N, Adams G, Buttery L, Falcone FH, Stolnik S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J. Biotechnol. 144, 304-312 (2009).
94. Tuch BE, Hughes TC, Evans MD. Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes Metab. Res. Rev. 27, 928-932 (2011).
95. Collins VP, James CD. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J. 7, 926-930 (1993).
96. Shah K. Mesenchymal stem cells engineered for cancer therapy. Adv. Drug Deliv. Rev. 64(8), 739-748 (2011).
97. Kauer TM, Figueiredo JL, Hingtgen S, Shah K. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat. Neurosci. 15, 197-204 (2011).
98. Rege TA, Fears CY, Gladson CL. Endogenous inhibitors of angiogenesis in malignant gliomas: Nature's antiangiogenic therapy. Neuro. Oncol. 7, 106-121 (2005).
99. Kleinschmidt K, Klinge PM, Stopa E et al. Alginate encapsulated human mesenchymal stem cells suppress syngeneic glioma growth in the immunocompetent rat. J. Microencapsul. 28, 621-627 (2011).
100. Goren A, Dahan N, Goren E, Baruch L, Machluf M. Encapsulated human mesenchymal stem cells: A unique hypoimmunogenic platform for long-term cellular therapy. FASEB J. 24, 22-31 (2010).
101. Lubiatowski P, Kruczynski J, Gradys A, Trzeciak T, Jaroszewski J. Articular cartilage repair by means of biodegradable scaffolds. Transplant. Proc. 38, 320-322 (2006).
102. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study. Am. J. Sports Med. 38, 1110-1116 (2010).
103. Barbero A, Grogan S, Schafer D, Heberer M, Mainil-Varlet P, Martin I. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarth. Cart. 12, 476-484 (2004).
104. Munirah S, Samsudin OC, Aminuddin BS, Ruszymah BH. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: A step towards exploring a potential use of matrix-induced cell therapy. Tissue Cell 42, 282-292 (2010).
105. Buckley CT, Meyer EG, Kelly DJ. The influence of construct scale on the composition and functional properties of cartilaginous tissues engineered using bone marrow-derived mesenchymal stem cells. Tissue Eng. A 18, 382-396 (2012).
106. Perrier E, Ronziere MC, Bareille R, Pinzano A, Mallein-Gerin F, Freyria AM. Analysis of collagen expression during chondrogenic induction of human bone marrow mesenchymal stem cells. Biotechnol. Lett. 33, 2091-2101 (2011).
107. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272 (1998).
108. Tuli R, Tuli S, Nandi S et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-Activated protein kinase and Wnt signaling cross-talk. J. Biol. Chem. 278, 41227-41236 (2003).
109. Mello MA, Tuan RS. Effects of TGF-beta1 and triiodothyronine on cartilage maturation: In vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J. Orthop. Res. 24, 2095-2105 (2006).
110. Patil AS, Sable RB, Kothari RM. An update on transforming growth factor-beta (TGF-beta): Sources, types, functions and clinical applicability for cartilage/bone healing. J. Cell. Physiol. 226, 3094-3103 (2011).
111. Solorio LD, Vieregge EL, Dhami CD, Dang PN, Alsberg E. Engineered cartilage via self-Assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-beta1. J. Control. Release 158, 224-232 (2011).
112. Dashtdar H, Rothan HA, Tay T et al. A preliminary study comparing the use of allogenic chondrogenic pre-differentiated and undifferentiated mesenchymal stem cells for the repair of full thickness articular cartilage defects in rabbits. J. Orthop. Res. 29, 1336-1342 (2011).
113. Diduch DR, Jordan LC, Mierisch CM, Balian G. Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy 16, 571-577 (2000).
114. Pili D, Tranquilli Leali P. Biomaterials and bone. Aging Clin. Exp. Res. 23, 74-75 (2011).
115. Kong HJ, Smith MK, Mooney DJ. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 24, 4023-4029 (2003).
116. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol. Prog. 17, 945-950 (2001).
117. Chen W, Zhou H, Tang M, Weir MD, Bao C, Xu HH. Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells. Tissue Eng. A 18(7-8), 816-827 (2011).
118. Zhao L, Weir MD, Xu HH. An injectable calcium phosphate-Alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 31, 6502-6510 (2010).
119. Zhou H, Xu HH. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 32, 7503-7513 (2011).
120. Mo XT, Guo SC, Xie HQ et al. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs. Bone 45, 42-51 (2009).
121. Huang S, Jia S, Liu G, Fang D, Zhang D. Osteogenic differentiation of muscle satellite cells induced by platelet-rich plasma encapsulated in three-dimensional alginate scaffold. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. doi: 10.1016/j. tripleo.2011.07.048 (2012) (Epub ahead of print).
122. Burridge PW, Keller G, Gold JD, Wu JC. Production of De novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming. Cell. Stem Cell. 10, 16-28 (2012).
123. Cortes-Morichetti M, Frati G, Schussler O et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng. 13, 2681-2687 (2007).
124. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654-660 (2004).
125. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112, I173-177 (2005).
126. Al Kindi AH, Asenjo JF, Ge Y et al. Microencapsulation to reduce mechanical loss of microspheres: Implications in myocardial cell therapy. Eur. J. Cardiothorac. Surg. 39, 241-247 (2011).
127. Tang J, Xie Q, Pan G, Wang J, Wang M. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg. 30, 353-361 (2006).
128. Xiang MX, He AN, Wang JA, Gui C. Protective paracrine effect of mesenchymal stem cells on cardiomyocytes. J. Zhejiang Univ. Sci. B 10, 619-624 (2009).
129. Nayan M, Paul A, Chen G, Chiu RC, Prakash S, Shum-Tim D. Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: In vitro and in vivo investigation. J. Tissue Eng. doi: 10.4061/2011/741213 (2011) (Epub).
130. Jing D, Parikh A, Tzanakakis ES. Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant. 19, 1397-1412 (2010).
131. Dalton PD, Mey J. Neural interactions with materials. Front. Biosci. 14, 769-795 (2009).
132. Prang P, Muller R, Eljaouhari A et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials 27, 3560-3569 (2006).
133. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 407, 963-970 (2000).
134. Li X, Liu T, Song K et al. Culture of neural stem cells in calcium alginate beads. Biotechnol. Prog. 22, 1683-1689 (2006).
135. Cunha C, Panseri S, Villa O, Silva D, Gelain F. 3D culture of adult mouse neural stem cells within functionalized self-Assembling peptide scaffolds. Int. J. Nanomedicine 6, 943-955 (2011).
136. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20, 1103-1110 (2002).
137. Matyash M, Despang F, Mandal R, Fiore D, Gelinsky M, Ikonomidou C. Novel soft alginate hydrogel strongly supports neurite growth and protects neurons against oxidative stress. Tissue Eng. A 18, 55-66 (2012).
138. Ashton RS, Banerjee A, Punyani S, Schaffer DV, Kane RS. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 28, 5518-5525 (2007).
139. Heile AM, Wallrapp C, Klinge PM et al. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci. Lett. 463, 176-181 (2009).
140. Klinge PM, Harmening K, Miller MC et al. Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer's disease. Neurosci. Lett. 497, 6-10 (2011).
141. Heile A, Brinker T. Clinical translation of stem cell therapy in traumatic brain injury: The potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1. Dialogues Clin. Neurosci. 13, 279-286 (2011).
142. Dvir-Ginzberg M, Elkayam T, Cohen S. Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. FASEB J. 22, 1440-1449 (2008).
143. Glicklis R, Shapiro L, Agbaria R, Merchuk JC, Cohen S. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol. Bioeng. 67, 344-353 (2000).
144. Khalil M, Shariat-Panahi A, Tootle R et al. Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J. Hepatol. 34, 68-77 (2001).
145. Hamazaki T, Iiboshi Y, Oka M et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett. 497, 15-19 (2001).
146. Zhou M, Li P, Tan L, Qu S, Ying QL, Song H. Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J. Cell. Biochem. 109, 606-614 (2010).
147. Maguire T, Novik E, Schloss R, Yarmush M. Alginate-PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol. Bioeng. 93, 581-591 (2006).
148. Trouche E, Girod Fullana S, Mias C et al. Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ. Cell Transplant. 19, 1623-1633 (2010).